Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.

Abstract

Iron deficiency and iron-deficiency anemia are associated with increased morbidity and mortality in a wide range of conditions. In many patient populations, this can be treated effectively with oral iron supplementation; but in patients who are unable to take or who do not respond to oral iron therapy, intravenous iron administration is recommended. Furthermore, in certain conditions, such as end-stage kidney disease, chronic heart failure, and inflammatory bowel disease, intravenous iron administration has become first-line treatment. One of the first available intravenous iron preparations is iron sucrose (Venofer®), a nanomedicine that has been used clinically since 1949. Treatment with iron sucrose is particularly beneficial owing to its ability to rapidly increase hemoglobin, ferritin, and transferrin saturation levels, with an acceptable safety profile. Recently, important new data relating to the use of iron sucrose, including the findings from the landmark PIVOTAL trial in patients with end-stage kidney disease, have been reported. Several years ago, a number of iron sucrose similars became available, although there have been concerns about the clinical appropriateness of substituting the original iron sucrose with an iron sucrose similar because of differences in efficacy and safety. This is a result of the complex and unique physicochemical properties of nanomedicines such as iron sucrose, which make copying the molecule difficult and problematic. In this review, we summarize the evidence accumulated during 70 years of clinical experience with iron sucrose in terms of efficacy, safety, and cost-effectiveness.

• Authors: Iain C Macdougall, Josep Comin-Colet, Christian Breymann, Donat R Spahn, Ioannis E Koutroubakis
• Journal: Advances in therapy (Adv Ther) Vol. 37 Issue 5 Pg. 1960-2002 (05 2020) ISSN: 1865-8652 [Electronic] United States
• PMID: 32297281 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Ferric Compounds
• Hematinics
• Ferric Oxide, Saccharated

Topics

• Anemia, Iron-Deficiency (drug therapy, prevention & control)
• Ferric Compounds (therapeutic use)
• Ferric Oxide, Saccharated (therapeutic use)
• Hematinics (therapeutic use)
• Humans
• Kidney Failure, Chronic (therapy)